Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 1
1984 1
1986 2
1987 2
1988 2
1989 1
1990 1
1991 4
1992 1
1993 1
1994 3
1995 1
1996 5
1997 3
1998 5
1999 4
2000 5
2001 2
2002 6
2003 3
2004 3
2005 2
2006 5
2007 2
2008 3
2009 4
2010 5
2011 2
2012 2
2013 4
2014 3
2015 3
2016 4
2017 7
2018 6
2019 1
2020 2
2021 3
2022 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group. Feagan BG, et al. N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734. N Engl J Med. 2013. PMID: 23964932 Free article. Clinical Trial.
ESPEN practical guideline: Clinical nutrition in chronic intestinal failure.
Cuerda C, Pironi L, Arends J, Bozzetti F, Gillanders L, Jeppesen PB, Joly F, Kelly D, Lal S, Staun M, Szczepanek K, Van Gossum A, Wanten G, Schneider SM, Bischoff SC; Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN. Cuerda C, et al. Among authors: staun m. Clin Nutr. 2021 Sep;40(9):5196-5220. doi: 10.1016/j.clnu.2021.07.002. Epub 2021 Aug 2. Clin Nutr. 2021. PMID: 34479179
ESPEN guidelines on chronic intestinal failure in adults.
Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, Joly F, Kelly D, Lal S, Staun M, Szczepanek K, Van Gossum A, Wanten G, Schneider SM; Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN. Pironi L, et al. Among authors: staun m. Clin Nutr. 2016 Apr;35(2):247-307. doi: 10.1016/j.clnu.2016.01.020. Epub 2016 Feb 8. Clin Nutr. 2016. PMID: 26944585
ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.
Pironi L, Arends J, Baxter J, Bozzetti F, Peláez RB, Cuerda C, Forbes A, Gabe S, Gillanders L, Holst M, Jeppesen PB, Joly F, Kelly D, Klek S, Irtun Ø, Olde Damink SW, Panisic M, Rasmussen HH, Staun M, Szczepanek K, Van Gossum A, Wanten G, Schneider SM, Shaffer J; Home Artificial Nutrition & Chronic Intestinal Failure; Acute Intestinal Failure Special Interest Groups of ESPEN. Pironi L, et al. Among authors: staun m. Clin Nutr. 2015 Apr;34(2):171-80. doi: 10.1016/j.clnu.2014.08.017. Epub 2014 Sep 21. Clin Nutr. 2015. PMID: 25311444 Free article.
[Pregnancy-related thrombocytosis].
Jønsson V, Bock JE, Mortensen TH, Staun M, Thorsen S. Jønsson V, et al. Among authors: staun m. Ugeskr Laeger. 2002 Aug 19;164(34):3946-9. Ugeskr Laeger. 2002. PMID: 12212474 Review. Danish.
Intestinal transplantation.
Pironi L, Staun M, Van Gossum A. Pironi L, et al. Among authors: staun m. N Engl J Med. 2009 Dec 10;361(24):2388-9; author reply 2389. doi: 10.1056/NEJMc0909351. N Engl J Med. 2009. PMID: 20007566 No abstract available.
Diagnosis and treatment of fistulising Crohn's disease.
Hvas CL, Dahlerup JF, Jacobsen BA, Ljungmann K, Qvist N, Staun M, Tøttrup A. Hvas CL, et al. Among authors: staun m. Dan Med Bull. 2011 Oct;58(10):C4338. Dan Med Bull. 2011. PMID: 21975159 Free article. Review.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group. Peyrin-Biroulet L, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798039 Free article. Clinical Trial.
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group. Vermeire S, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798037 Clinical Trial.
106 results